Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Comparison of the Efficacy of Nilotinib and Imatinib in the Treatment of Chronic Myeloid Leukemia.

< BACK TO ARCHIVE


2019 Jul


J Coll Physicians Surg Pak


http://www.ncbi.nlm.nih.gov/pubmed/31253213?dopt=Abstract


29


7

Comparison of the Efficacy of Nilotinib and Imatinib in the Treatment of Chronic Myeloid Leukemia.

Authors

Comparison of the Efficacy of Nilotinib and Imatinib in the Treatment of Chronic Myeloid Leukemia.
Zhang B-S, Chen Y-P, Lv J-L, Yang Y
J Coll Physicians Surg Pak. 2019 Jul; 29(7):631-634.
PMID: 31253213.

Abstract

To compare the efficacy of nilotinib and imatinib in the treatment of chronic myeloid leukemia (CML).
Read This Paper